Skip to main content
OpenTrials
Active, Not Recruiting

NCT Number: NCT07622160

Efficacy Test of a Moisturizing and Anti-aging Facial Mask

The objective of this study is to evaluate the effect of Moisturizing facial mask and Anti-aging facial mask on human skin condition improvement.

Active, Not Recruiting

This study is active but is not currently recruiting participants.

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Chia Nan University of Pharmacy & Science

Pingdong, Taiwan

About this study

This study is a single-center, self-controlled human trial designed to evaluate the skin beauty effect of Moisturizing facial mask and Anti-aging facial mask.

Healthy adult participants aged above 18 years will be enrolled. Participants will be informed to apply the facial mask on whole face three times per week for 4 consecutive weeks. Skin measurement and self-assessment questionnaires will be conducted at baseline (before intake), after single use, and after continuous use for 2 and 4 weeks.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Participants aged 18 years or older

Exclusion criteria

  • Non-voluntary participants.
  • Individuals diagnosed by a physician with skin diseases, liver cirrhosis, or chronic renal failure.
  • Individuals with known allergies to cosmetics, medications, or foods.
  • Pregnant or breastfeeding individuals.
  • Individuals taking medications for chronic diseases.
  • Students taught or supervised by the principal investigator.

Treatment and study plan

Hydrating Repairing Mask

Other

Applying the facial mask three times per week for a continuous period of 4 weeks

Other names: seibella Hydrating Repairing Mask

Anti-aging Rejuvenating Mask

Other

Applying the facial mask three times per week for a continuous period of 4 weeks

Other names: seibella Anti-aging Rejuvenating Mask

Primary outcomes

  1. The change of skin hydration

    Time frame: Change from Baseline skin hydration at 4 weeks

    Corneometer® CM825 (CK, Germany) was utilized to measure skin surface hydation. Units: arbitrary Corneometer® units 0-120.

  2. The change of skin redness

    Time frame: Change from Baseline skin redness at 4 weeks

    Chroma Meter MM500 was utilized to measure face skin redness. Units: a* value

  3. The change of skin texture

    Time frame: Change from Baseline skin texture at 4 weeks

    VISIA Complexion Analysis was utilized to measure skin texture. Units: arbitrary units

  4. The change of skin wrinkles

    Time frame: Change from Baseline skin wrinkles at 4 weeks

    VISIA Complexion Analysis was utilized to measure skin wrinkles. Units: arbitrary units

Secondary outcomes

  1. The change of transepidermal water loss (TEWL)

    Time frame: Change from Baseline TEWL at 4 weeks

    Tewameter® TM300 (CK, Germany) was utilized to measure TEWL. Units: g/hm²

  2. The change of skin tone

    Time frame: Change from Baseline skin tone at 4 weeks

    Chroma Meter MM500 was utilized to measure face skin tone. Units: Individual Typology Angle (ITA°)

  3. The change of skin pores

    Time frame: Change from Baseline skin pores at 4 weeks

    VISIA Complexion Analysis was utilized to measure skin pores. Units: arbitrary units

  4. The change of skin elasticity

    Time frame: Change from Baseline skin elasticity at 4 weeks

    Skin elasticity (Softplus, Italy) was utilized to measure face skin elasticity. Units: arbitrary units

  5. The change of skin collagen density

    Time frame: Change from Baseline skin collagen density at 4 weeks

    DermaLab® Series SkinLab Combo was utilized to measure skin collagen density. Units: arbitrary units

Other outcomes

  1. The change of self-assessment skin condition

    Time frame: Change from Baseline skin condition at 4 weeks

    Skin condition was evaluated using a 5-point Likert scale (0-4) to assess the severity of skin-related symptoms. The scale was defined as follows: 0 = none, 1 = mild, 2 = moderate, 3 = severe, and 4 = very severe.

Sponsors and collaborators

Lead sponsor

TCI Co., Ltd.

Industry

Registry information

Official study title

Efficacy Test of a Moisturizing and Anti-aging Facial Mask for Skin Improvement

Important dates

Study start
2026
Primary completion
2026
Study completion
2026
First posted
Jun 3, 2026
Registry last updated
Jun 3, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.